Zobrazeno 1 - 10
of 11
pro vyhledávání: '"J N, Lozier"'
Autor:
J. N. Lozier
Publikováno v:
JAMA: The Journal of the American Medical Association. 271:47-51
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 17(4)
Several genes that modify risk of factor VIII (FVIII) inhibitors in haemophilia A patients have been identified. Aside from the underlying mutations that cause haemophilia A, inhibitor risk appears to be modified by polymorphisms in various cytokines
Publikováno v:
Bone marrow transplantation. 44(7)
Chronic graft versus host disease (cGVHD) is a major and frequent late complication in allogeneic stem cell transplantation recipients. Although thrombocytopenia in cGVHD patients is among the most consistent and strongest predictors of poor survival
Publikováno v:
Blood. 94(12)
We used a first-generation adenovirus vector (AVC3FIX5) to assess whether human factor IX could be expressed and detected in the rhesus macaque, which we have shown does not make high-titer antibodies to human factor IX protein. Three animals receive
Publikováno v:
Blood. 93(6)
We have determined the 2905 nucleotide sequence of the rhesus macaque factor IX complementary DNA (cDNA) and found it to be greater than 95% identical to that of the human factor IX cDNA. The cDNA has a large 3' untranslated region like the human cDN
Autor:
C R, Hay, J N, Lozier, C A, Lee, M, Laffan, F, Tradati, E, Santagostino, N, Ciavarella, M, Schiavoni, H, Fukui, A, Yoshioka, J, Teitel, P M, Mannucci, C K, Kasper
Publikováno v:
Thrombosis and haemostasis. 75(1)
A multicentre retrospective survey was conducted to re-assess the use of porcine factor VIII (HYATE:C), its side effects and the selection of patients for regular or home-therapy. 15,152,000 units of HYATE:C were used by 154 patients. The median inhi
Autor:
C R, Hay, J N, Lozier, C A, Lee, M, Lafan, H, Tradati, E, Santagostino, N, Ciavarella, M, Schiavoni, H, Fukui, A, Yoshioka
Publikováno v:
Seminars in hematology. 31(2 Suppl 4)
Autor:
J N, Lozier, K M, Brinkhous
Publikováno v:
JAMA. 271(1)
Gene therapy for hemophilia A and B, now in the developmental stage, holds promise of a therapeutic revolution, resulting in amelioration or cure of the hemorrhagic diatheses. The genes for factor VIII and IX have been cloned, and vectors for the tra
Publikováno v:
Seminars in hematology. 30(2 Suppl 1)
We have described the use of polyelectrolyte fractionated porcine factor VIII (HYATE:C, Porton Speywood Ltd, Wrexham, UK) to provide hemostasis in 45 patients with hemophilia A complicated by inhibitor antibodies. The cases were collected from hemoph
Autor:
F. Giannelli, P. M. Green, K. A. High, J. N. Lozier, D. P. Lillicrap, M. Ludwig, K. Olek, P. H. Reitsma, M. Goossens, A. Yoshioka, S. Sommer, G. G. Brownlee
Publikováno v:
Nucleic acids research. 18(14)